Global Cannabinoids Market

1. Market Definition

The global cannabinoids market encompasses the production, distribution, and sale of chemical compounds derived from the Cannabis sativa plant, including THC, CBD, and minor cannabinoids like CBG and CBN. The scope includes pharmaceutical-grade formulations, adult-use recreational products, and industrial hemp-derived compounds for wellness and cosmetics, while excluding illicit trade and raw industrial fiber.

2. Trends & Demand Drivers

Several key trends are expected to significantly impact the Cannabinoids Market in the period 2025-30:

• The anticipated reclassification of cannabis to Schedule III in the U.S. is expected to significantly reduce tax burdens and unlock institutional capital.
• There is a rapid shift toward pharmaceutical-grade standardization and GMP-certified manufacturing to increase physician confidence and clinical adoption.
• Market growth is increasingly driven by product diversification, including the rise of fast-acting beverages, precision-dose edibles, and specialized topicals.
• Increasing clinical validation and FDA/EMA approvals for cannabinoid-based treatments are expanding the addressable market for chronic pain and neurological disorders.
• Advancements in extraction technologies and AI-driven cultivation are improving cannabinoid purity and reducing production costs for minor cannabinoids like CBG.
• The expansion of telehealth and digital prescribing workflows is reducing friction for patient acquisition in emerging European and Oceanic markets.
• A growing consumer preference for non-psychoactive compounds is fueling the integration of CBD and other isolates into mainstream functional foods and cosmetics.

3. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: